BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 28877884)

  • 1. Aberrant Smad3 phosphoisoforms in cyst-lining epithelial cells in the
    Hama T; Nakanishi K; Sato M; Mukaiyama H; Togawa H; Shima Y; Miyajima M; Nozu K; Nagao S; Takahashi H; Sako M; Iijima K; Yoshikawa N; Suzuki H
    Am J Physiol Renal Physiol; 2017 Dec; 313(6):F1223-F1231. PubMed ID: 28877884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smad2 and Smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-beta signal in later stages of human colorectal cancer.
    Matsuzaki K; Kitano C; Murata M; Sekimoto G; Yoshida K; Uemura Y; Seki T; Taketani S; Fujisawa J; Okazaki K
    Cancer Res; 2009 Jul; 69(13):5321-30. PubMed ID: 19531654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smad3 phosphoisoform-mediated signaling during sporadic human colorectal carcinogenesis.
    Matsuzaki K
    Histol Histopathol; 2006 Jun; 21(6):645-62. PubMed ID: 16528675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucin1 shifts Smad3 signaling from the tumor-suppressive pSmad3C/p21(WAF1) pathway to the oncogenic pSmad3L/c-Myc pathway by activating JNK in human hepatocellular carcinoma cells.
    Li Q; Liu G; Yuan H; Wang J; Guo Y; Chen T; Zhai R; Shao D; Ni W; Tai G
    Oncotarget; 2015 Feb; 6(6):4253-65. PubMed ID: 25714018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B.
    Murata M; Matsuzaki K; Yoshida K; Sekimoto G; Tahashi Y; Mori S; Uemura Y; Sakaida N; Fujisawa J; Seki T; Kobayashi K; Yokote K; Koike K; Okazaki K
    Hepatology; 2009 Apr; 49(4):1203-17. PubMed ID: 19263472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic Smad3 signaling induced by chronic inflammation is an early event in ulcerative colitis-associated carcinogenesis.
    Kawamata S; Matsuzaki K; Murata M; Seki T; Matsuoka K; Iwao Y; Hibi T; Okazaki K
    Inflamm Bowel Dis; 2011 Mar; 17(3):683-95. PubMed ID: 20602465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of Smad3 phosphoisoform-mediated signaling in the development of colonic cancer in IL-10-deficient mice.
    Hachimine D; Uchida K; Asada M; Nishio A; Kawamata S; Sekimoto G; Murata M; Yamagata H; Yoshida K; Mori S; Tahashi Y; Matsuzaki K; Okazaki K
    Int J Oncol; 2008 Jun; 32(6):1221-6. PubMed ID: 18497983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma.
    Matsuzaki K; Murata M; Yoshida K; Sekimoto G; Uemura Y; Sakaida N; Kaibori M; Kamiyama Y; Nishizawa M; Fujisawa J; Okazaki K; Seki T
    Hepatology; 2007 Jul; 46(1):48-57. PubMed ID: 17596875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta during carcinogenesis: the shift from epithelial to mesenchymal signaling.
    Matsuzaki K; Okazaki K
    J Gastroenterol; 2006 Apr; 41(4):295-303. PubMed ID: 16741607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial-to-mesenchymal transition in cyst lining epithelial cells in an orthologous PCK rat model of autosomal-recessive polycystic kidney disease.
    Togawa H; Nakanishi K; Mukaiyama H; Hama T; Shima Y; Sako M; Miyajima M; Nozu K; Nishii K; Nagao S; Takahashi H; Iijima K; Yoshikawa N
    Am J Physiol Renal Physiol; 2011 Feb; 300(2):F511-20. PubMed ID: 21084407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta during human colorectal carcinogenesis: the shift from epithelial to mesenchymal signaling.
    Matsuzaki K; Seki T; Okazaki K
    Inflammopharmacology; 2006 Dec; 14(5-6):198-203. PubMed ID: 17093904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiorgan mRNA misexpression in murine autosomal recessive polycystic kidney disease.
    Gattone VH; Ricker JL; Trambaugh CM; Klein RM
    Kidney Int; 2002 Nov; 62(5):1560-9. PubMed ID: 12371956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of c-Jun NH2-terminal kinase switches Smad3 signaling from oncogenesis to tumor- suppression in rat hepatocellular carcinoma.
    Nagata H; Hatano E; Tada M; Murata M; Kitamura K; Asechi H; Narita M; Yanagida A; Tamaki N; Yagi S; Ikai I; Matsuzaki K; Uemoto S
    Hepatology; 2009 Jun; 49(6):1944-53. PubMed ID: 19418558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smad3 and its phosphoisoforms are prognostic predictors of hepatocellular carcinoma after curative hepatectomy.
    Kim SH; Ahn S; Park CK
    Hepatobiliary Pancreat Dis Int; 2012 Feb; 11(1):51-9. PubMed ID: 22251470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-37 suppresses hepatocellular carcinoma growth by converting pSmad3 signaling from JNK/pSmad3L/c-Myc oncogenic signaling to pSmad3C/P21 tumor-suppressive signaling.
    Liu R; Tang C; Shen A; Luo H; Wei X; Zheng D; Sun C; Li Z; Zhu D; Li T; Wu Z
    Oncotarget; 2016 Dec; 7(51):85079-85096. PubMed ID: 27835881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of autosomal recessive polycystic kidney disease in BALB/c-cpk/cpk mice.
    Ricker JL; Gattone VH; Calvet JP; Rankin CA
    J Am Soc Nephrol; 2000 Oct; 11(10):1837-1847. PubMed ID: 11004214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceleration of Smad2 and Smad3 phosphorylation via c-Jun NH(2)-terminal kinase during human colorectal carcinogenesis.
    Yamagata H; Matsuzaki K; Mori S; Yoshida K; Tahashi Y; Furukawa F; Sekimoto G; Watanabe T; Uemura Y; Sakaida N; Yoshioka K; Kamiyama Y; Seki T; Okazaki K
    Cancer Res; 2005 Jan; 65(1):157-65. PubMed ID: 15665291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ezrin distribution is abnormal in principal cells from a murine model of autosomal recessive polycystic kidney disease.
    Orellana SA; QuinoƱes AM; Mandapat ML
    Pediatr Res; 2003 Sep; 54(3):406-12. PubMed ID: 12840161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophages promote polycystic kidney disease progression.
    Swenson-Fields KI; Vivian CJ; Salah SM; Peda JD; Davis BM; van Rooijen N; Wallace DP; Fields TA
    Kidney Int; 2013 May; 83(5):855-64. PubMed ID: 23423256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smad3 and Smad3 phosphoisoforms are prognostic markers of gastric carcinoma.
    Kim SH; Kim KH; Ahn S; Hyeon J; Park CK
    Dig Dis Sci; 2013 Apr; 58(4):989-97. PubMed ID: 23179147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.